|
1-[(7Z,10Z,13Z,16Z,19Z)-docosapentaenoyl]-sn-glycero-3-phosphocholine |
|
CHEBI:133734 |
|
1-[(7Z,10Z,13Z,16Z,19Z)-docosapentaenoyl]-sn-glycero-3-phosphocholine |
|
A 1-O-acyl-sn-glycero-3-phosphocholine in which the acyl group is specified as (7Z,10Z,13Z,16Z,19Z)-docosapentaenoyl. |
|
This entity has been manually annotated by the ChEBI Team.
|
|
CHEBI:88949
|
|
|
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C30H52NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-30(33)36-27-29(32)28-38-39(34,35)37-26-25-31(2,3)4/h6-7,9-10,12-13,15-16,18-19,29,32H,5,8,11,14,17,20-28H2,1-4H3/b7-6-,10-9-,13-12-,16-15-,19-18-/t29-/m1/s1 |
BIEOSECQPGGZMF-NAIWXXGBSA-N |
O(C[C@H](COP(OCC[N+](C)(C)C)(=O)[O-])O)C(CCCCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)=O |
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via lysophosphatidylcholine 22:5 )
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
(via lysophosphatidylcholine )
|
|
View more via ChEBI Ontology
Outgoing
|
1-[(7Z,10Z,13Z,16Z,19Z)-docosapentaenoyl]-sn-glycero-3-phosphocholine
(CHEBI:133734)
has functional parent
(7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid
(CHEBI:53488)
1-[(7Z,10Z,13Z,16Z,19Z)-docosapentaenoyl]-sn-glycero-3-phosphocholine
(CHEBI:133734)
is a
1-O-acyl-sn-glycero-3-phosphocholine
(CHEBI:58168)
1-[(7Z,10Z,13Z,16Z,19Z)-docosapentaenoyl]-sn-glycero-3-phosphocholine
(CHEBI:133734)
is a
lysophosphatidylcholine (22:5/0:0)
(CHEBI:131985)
|
|
(2R)-3-[(7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16-pentaenoyloxy]-2-hydroxypropyl 2-(trimethylammonio)ethyl phosphate
|
1-Docosapentaenoyl-glycero-3-phosphocholine
|
HMDB
|
1-docosapentaenoyl-GPC
|
ChEBI
|
1-docosapentaenoyl-GPC (22:5n3)
|
ChEBI
|
GPC(22:5n3)
|
ChEBI
|
LPC(22:5(7Z,10Z,13Z,16Z,19Z)/0:0)
|
ChEBI
|
LPC(22:5)
|
HMDB
|
LPC(22:5/0:0)
|
ChEBI
|
LPC(22:5n3/0:0)
|
HMDB
|
LPC(22:5w3/0:0)
|
HMDB
|
LyPC(22:5)
|
HMDB
|
LyPC(22:5/0:0)
|
HMDB
|
LyPC(22:5n3/0:0)
|
HMDB
|
LyPC(22:5w3/0:0)
|
HMDB
|
LysoPC(22:5)
|
HMDB
|
LysoPC(22:5/0:0)
|
HMDB
|
LysoPC(22:5n3/0:0)
|
HMDB
|
LysoPC(22:5w3/0:0)
|
HMDB
|
lysophosphatidylcholine(22:5(7Z,10Z,13Z,16Z,19Z)/0:0)
|
ChEBI
|
Lysophosphatidylcholine(22:5)
|
HMDB
|
Lysophosphatidylcholine(22:5/0:0)
|
HMDB
|
lysophosphatidylcholine(22:5/0:0)
|
ChEBI
|
Lysophosphatidylcholine(22:5n3/0:0)
|
HMDB
|
Lysophosphatidylcholine(22:5w3/0:0)
|
HMDB
|
PC(22:5(7Z,10Z,13Z,16Z,19Z)/0:0)
|
ChEBI
|
PC(22:5/0:0)
|
ChEBI
|
PC(22:5n3)
|
ChEBI
|
18953024
|
PubMed citation
|
Europe PMC
|
|